Kinetic titration series with biolayer interferometry

Daniel Frenzel1, Dieter Willbold2

  • 1Forschungszentrum Jülich, ICS-6 Structural Biochemistry, Jülich, Germany.

Plos One
|September 18, 2014
PubMed

Insights

This study demonstrates kinetic titration series for biolayer interferometry, enabling precise, real-time analysis of high-affinity protein interactions like immunoglobulin G and scFv IC16 with amyloid beta. This method enhances efficiency and accuracy in characterizing molecular binding events.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Background:

  • Biolayer interferometry (BLI) is a label-free optical technique for real-time analysis of biomolecular interactions.
  • Characterizing high-affinity protein-ligand interactions quantitatively is crucial in drug discovery and diagnostics.
  • Kinetic titration series are established for surface plasmon resonance (SPR) but their application in BLI requires validation.

Purpose of the Study:

  • To demonstrate the straightforward application of kinetic titration series to biolayer interferometry for quantitative analysis of protein-ligand interactions.
  • To characterize the binding kinetics of immunoglobulin G (IgG) with Protein G B1 and scFv IC16 with amyloid beta (1-42) using this method.
  • To highlight the advantages of kinetic titration series in BLI, including circumvention of sensor variability, resource savings, and increased throughput.

Main Methods:

  • Utilized biolayer interferometry for real-time interaction analysis.
  • Employed kinetic titration series, involving sequential analyte injections over a concentration range on a single ligand-coated sensor chip.
  • Characterized interactions between immunoglobulin G and Protein G B1, and between scFv IC16 and amyloid beta (1-42).

Main Results:

  • Successfully applied kinetic titration series to biolayer interferometry for quantitative analysis of high-affinity protein-ligand interactions.
  • Demonstrated the method's ability to accurately characterize binding kinetics for both IgG/Protein G B1 and scFv IC16/amyloid beta pairs.
  • Validated that the BLI kinetic titration approach circumvents data evaluation issues from sensor differences.

Conclusions:

  • Kinetic titration series are effectively transferable to biolayer interferometry, offering a robust method for real-time, quantitative interaction analysis.
  • This approach significantly improves resource efficiency and throughput for screening numerous analyte/ligand combinations.
  • The method provides a valuable tool for researchers studying high-affinity biomolecular interactions in various biological contexts.